2022 - Research.com Best Scientist Award
His scientific interests lie mostly in Quality of life, Internal medicine, Cancer, Physical therapy and Clinical trial. His work in Quality of life tackles topics such as Psychometrics which are related to areas like Item response theory, Computerized adaptive testing, Activities of daily living and Family medicine. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Surgery and Oncology.
His work focuses on many connections between Surgery and other disciplines, such as Renal cell carcinoma, that overlap with his field of interest in Sorafenib. The Cancer study combines topics in areas such as Gynecologic oncology, MEDLINE, Distress, Anemia and Ambulatory. David Cella combines subjects such as Psychological intervention, Cancer-related fatigue, Disease, Cancer therapy and Severity of illness with his study of Physical therapy.
His primary areas of study are Internal medicine, Quality of life, Physical therapy, Cancer and Oncology. His study ties his expertise on Surgery together with the subject of Internal medicine. David Cella works mostly in the field of Quality of life, limiting it down to concerns involving Psychometrics and, occasionally, Item response theory.
His biological study deals with issues like Quality of life, which deal with fields such as Intensive care medicine and Family medicine. His Cancer research is multidisciplinary, incorporating perspectives in Lung cancer, Anemia and Gerontology. His Oncology research integrates issues from Prostate cancer and Chemotherapy.
His primary scientific interests are in Internal medicine, Quality of life, Oncology, Clinical psychology and Physical therapy. His study in the field of Cancer, Clinical trial, Breast cancer and Lower urinary tract symptoms is also linked to topics like In patient. Cancer is closely attributed to Quality of life in his study.
His Quality of life research incorporates themes from Psychological intervention, Randomized controlled trial, Cronbach's alpha, Disease and Pediatrics. His work in Clinical psychology tackles topics such as Item response theory which are related to areas like Metric. His work in Physical therapy covers topics such as Ventricular assist device which are related to areas like Implant.
His main research concerns Internal medicine, Quality of life, Clinical psychology, Oncology and Clinical trial. As part of his studies on Internal medicine, he often connects relevant areas like Placebo. His studies deal with areas such as Psychometrics, Cross-sectional study, Cronbach's alpha, Disease and Atopic dermatitis as well as Quality of life.
His biological study spans a wide range of topics, including Patient-Reported Outcomes Measurement Information System, Item response theory, Differential item functioning, Convergent validity and Discriminant validity. His research on Patient-Reported Outcomes Measurement Information System also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
D F Cella;D S Tulsky;G Gray;B Sarafian.
Journal of Clinical Oncology (1993)
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Kathy Miller;Molin Wang;Julie Gralow;Maura Dickler.
The New England Journal of Medicine (2007)
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial
Mark G. Kris;Ronald B. Natale;Roy S. Herbst;Thomas J. Lynch.
The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008
David Cella;William Riley;Arthur Stone;Nan Rothrock.
Journal of Clinical Epidemiology (2010)
Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations
Robert H. Dworkin;Dennis C. Turk;Kathleen W. Wyrwich;Dorcas Beaton.
The Journal of Pain (2008)
The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.
David Cella;Susan Yount;Susan Yount;Nan Rothrock;Richard Gershon;Richard Gershon.
Medical Care (2007)
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Brian I. Rini;Bernard Escudier;Piotr Tomczak;Andrey Kaprin.
The Lancet (2011)
Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
Suzanne B. Yellen;David F. Cella;Kimberly Webster;Carol Blendowski.
Journal of Pain and Symptom Management (1997)
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Robert J. Motzer;Thomas E. Hutson;David Cella;James Reeves.
The New England Journal of Medicine (2013)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.
Dennis A. Revicki;Ron D. Hays;David Cella;Jeff A. Sloan.
Journal of Clinical Epidemiology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: